SG10201804052UA - hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS - Google Patents

hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS

Info

Publication number
SG10201804052UA
SG10201804052UA SG10201804052UA SG10201804052UA SG10201804052UA SG 10201804052U A SG10201804052U A SG 10201804052UA SG 10201804052U A SG10201804052U A SG 10201804052UA SG 10201804052U A SG10201804052U A SG 10201804052UA SG 10201804052U A SG10201804052U A SG 10201804052UA
Authority
SG
Singapore
Prior art keywords
pro
inflammatory mediators
umbilical cord
cord tissue
lung
Prior art date
Application number
SG10201804052UA
Other languages
English (en)
Inventor
Anthony J Kihm
Original Assignee
Depuy Synthes Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Depuy Synthes Products Inc filed Critical Depuy Synthes Products Inc
Publication of SG10201804052UA publication Critical patent/SG10201804052UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/51Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG10201804052UA 2012-05-14 2013-05-14 hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS SG10201804052UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/471,095 US20130302283A1 (en) 2012-05-14 2012-05-14 hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS

Publications (1)

Publication Number Publication Date
SG10201804052UA true SG10201804052UA (en) 2018-07-30

Family

ID=48577869

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201804052UA SG10201804052UA (en) 2012-05-14 2013-05-14 hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
SG11201407376SA SG11201407376SA (en) 2012-05-14 2013-05-14 hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201407376SA SG11201407376SA (en) 2012-05-14 2013-05-14 hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS

Country Status (18)

Country Link
US (1) US20130302283A1 (ja)
EP (1) EP2854825B1 (ja)
JP (2) JP6647863B2 (ja)
KR (2) KR20150009586A (ja)
CN (1) CN104736160A (ja)
AU (1) AU2013262946B2 (ja)
BR (1) BR112014028409A2 (ja)
CA (1) CA2872591C (ja)
ES (1) ES2702349T3 (ja)
HK (1) HK1208381A1 (ja)
IN (1) IN2014DN09084A (ja)
MX (1) MX366152B (ja)
PH (1) PH12014502508A1 (ja)
PL (1) PL2854825T3 (ja)
RU (1) RU2668389C2 (ja)
SG (2) SG10201804052UA (ja)
WO (1) WO2013173376A1 (ja)
ZA (1) ZA201409184B (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120156134A1 (en) 2007-12-20 2012-06-21 Shayne Squires Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
CA2747794C (en) 2008-12-19 2018-10-30 Advanced Technologies And Regenerative Medicine, Llc Treatment of lung and pulmonary diseases and disorders
WO2012177927A1 (en) 2011-06-21 2012-12-27 Mayo Foundation For Medical Education And Research Transgenic animals capable of being induced to delete senescent cells
MX2014007093A (es) 2011-12-13 2014-10-13 Buck Inst For Res On Aging Metodos para mejorar terapias medicas.
WO2013158664A2 (en) 2012-04-17 2013-10-24 Kythera Biopharmaceuticals, Inc. Use of engineered viruses to specifically kill senescent cells
US9901080B2 (en) 2012-08-23 2018-02-27 Buck Institute For Research On Aging Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
US9901081B2 (en) 2012-08-23 2018-02-27 Buck Institute For Research On Aging Transgenic mouse for determining the role of senescent cells in cancer
US10279018B2 (en) 2012-12-03 2019-05-07 Unity Biotechnology, Inc. Immunogenic compositions for inducing an immune response for elimination of senescent cells
AU2015211021B2 (en) 2014-01-28 2020-07-02 Buck Institute For Research On Aging Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders
US10328058B2 (en) 2014-01-28 2019-06-25 Mayo Foundation For Medical Education And Research Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques
WO2015116735A1 (en) 2014-01-28 2015-08-06 Mayo Foundation For Medical Education And Research Methods and combinations for killing senescent cells and for treating senescence-associated diseases and disorders
CN105420184A (zh) * 2015-12-11 2016-03-23 郭镭 一种从脐带外层羊膜组织中分离培养脐带间充质干细胞的方法
CN105462919A (zh) * 2015-12-11 2016-04-06 郭镭 一种从脐带华通氏胶组织中分离提取hUC-MSC的方法
WO2017096607A1 (zh) * 2015-12-11 2017-06-15 郭镭 一种从脐带外层羊膜组织中分离提取hUC-MSC的方法
WO2017096615A1 (zh) * 2015-12-11 2017-06-15 郭镭 一种从脐带华通氏胶组织中分离提取hUC-MSC的方法
WO2017096618A1 (zh) * 2015-12-11 2017-06-15 郭镭 一种从脐带外层羊膜组织中分离培养脐带间充质干细胞的方法
EP3388512B1 (en) * 2015-12-11 2023-08-23 Lei Guo Method for separating and culturing mesenchymal stem cells from wharton's jelly tissue of umbilical cord
CN105420185A (zh) * 2015-12-11 2016-03-23 郭镭 一种从脐带外层羊膜组织中分离提取hUC-MSC的方法
WO2019083995A1 (en) * 2017-10-23 2019-05-02 Cell Medicine, Inc. MESENCHYMAL STEM CELL THERAPY OF LEIGH SYNDROME
CA3115291A1 (en) * 2018-10-05 2020-04-09 Board Of Regents, The University Of Texas System Methods for the expansion of mesenchymal stromal cells
US11975030B2 (en) 2019-03-19 2024-05-07 Figene, Llc Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereof
US20230091910A1 (en) * 2019-04-02 2023-03-23 Centagen, Inc. Engineered System of Stem Cell Rejuvenation to Treat Aging and Disease
CN110923308A (zh) * 2019-12-12 2020-03-27 河南师范大学 特发性肺纤维化疾病诊断标志物及其制备诊断或预后工具中的应用
WO2021183774A1 (en) * 2020-03-12 2021-09-16 Angion Biomedica Corp. Treating acute respiratory distress
CN112511569B (zh) * 2021-02-07 2021-05-11 杭州筋斗腾云科技有限公司 网络资源访问请求的处理方法、系统及计算机设备

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955343A (en) 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US6610540B1 (en) 1998-11-18 2003-08-26 California Institute Of Technology Low oxygen culturing of central nervous system progenitor cells
KR100696408B1 (ko) 1999-04-16 2007-03-19 더블유엠. 마쉬 라이스 유니버시티 폴리(에틸렌글리콜)과 가교결합을 이룬 폴리(프로필렌푸마레이트)
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
US6555374B1 (en) 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
US7449180B2 (en) 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
WO2002062961A2 (en) 2001-02-06 2002-08-15 Massachusetts Institute Of Technology Peptide scaffold encapsulation of tissue cells and uses thereof
US9969980B2 (en) 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US9969977B2 (en) 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
JP5148873B2 (ja) * 2003-06-27 2013-02-20 エチコン、インコーポレイテッド 臍帯組織由来の分娩後細胞、及びその作成及び使用方法
BRPI0921999B8 (pt) * 2008-11-21 2021-05-25 Anthrogenesis Corp uso de uma quantidade terapeuticamente eficaz de células tronco placentárias
CA2747794C (en) * 2008-12-19 2018-10-30 Advanced Technologies And Regenerative Medicine, Llc Treatment of lung and pulmonary diseases and disorders
AU2010229651B2 (en) * 2009-03-26 2014-05-08 Advanced Technologies And Regenerative Medicine, Llc Human umbilical cord tissue cells as therapy for Alzheimer' s disease
DK2624847T3 (en) * 2010-10-05 2017-10-09 Aal Scient Inc HUMAN LUNG STEM CELLS AND APPLICATIONS THEREOF

Also Published As

Publication number Publication date
WO2013173376A1 (en) 2013-11-21
CA2872591A1 (en) 2013-11-21
EP2854825A1 (en) 2015-04-08
AU2013262946A1 (en) 2015-01-22
CA2872591C (en) 2021-11-30
HK1208381A1 (en) 2016-03-04
ZA201409184B (en) 2017-06-28
IN2014DN09084A (ja) 2015-05-22
EP2854825B1 (en) 2018-10-31
SG11201407376SA (en) 2015-03-30
MX366152B (es) 2019-06-28
PH12014502508B1 (en) 2014-12-22
JP2018118984A (ja) 2018-08-02
MX2014014027A (es) 2015-02-10
JP6779931B2 (ja) 2020-11-04
KR20180136560A (ko) 2018-12-24
ES2702349T3 (es) 2019-02-28
RU2014150508A (ru) 2016-07-10
RU2668389C2 (ru) 2018-09-28
JP6647863B2 (ja) 2020-02-14
BR112014028409A2 (pt) 2018-07-24
AU2013262946B2 (en) 2018-02-01
PH12014502508A1 (en) 2014-12-22
CN104736160A (zh) 2015-06-24
JP2015518830A (ja) 2015-07-06
PL2854825T3 (pl) 2019-04-30
US20130302283A1 (en) 2013-11-14
KR20150009586A (ko) 2015-01-26

Similar Documents

Publication Publication Date Title
SG10201804052UA (en) hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
AU2018236800B2 (en) DNA-PK inhibitors
CY1118105T1 (el) Αγγειογενεση χρησιμοποιωντας πλακουντιακα βλαστικα κυτταρα
MX2017013562A (es) Reguladores de microbioma y usos relacionados de los mismos.
MD4733B1 (ro) Anticorpi anti-TIGIT
MX2017004691A (es) Bloqueo de cd73.
PH12016500866A1 (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
PH12017500841B1 (en) 2-amino-6-(difluoromethyl)- 5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
PH12018502056A1 (en) Methods of treatment of cholestatic diseases
PH12016501600A1 (en) 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease
NZ708144A (en) Recombinant adenoviruses and use thereof
MX354662B (es) Anticuerpos fosfoespecificos que reconocen la tau.
MX2013010343A (es) Composicion y metodos para el transplante de microbiota de colon.
PH12020550660A1 (en) Cultivation of placenta to isolate exosomes
MX338421B (es) Anticuerpos fosfoespecificos que reconocen la proteina tau.
MX2017009417A (es) Formas solidas de acido 2-(5-(3-fluorofenil)-3-hidroxipicolinamido )acetico, composiciones y usos de las mismas.
BR112015020001A2 (pt) população de células-tronco no colo uterino humano
EA201790315A1 (ru) Модуляторы x-рецепторов печени
AR099557A1 (es) Fgf-18 en trasplantes de injertos y procedimientos de ingeniería de tejido
MX356814B (es) Métodos y composiciones para neuroprotección.
GB0712524D0 (en) Novel schizophrenia associated genes
WO2016014992A3 (en) Compositions for treatment, diagnosis and prognosis of diseases
TH171439A (th) การมอดูเลต hUTC ของตัวสื่อกลางที่กระตุ้นให้เกิดการอักเสบของโรค และความผิดปกติของปอดและระบบปอด
Covan Culture in sexual socialization.